The best trading opportunities hiding in this sector... Â [Unsubscribe]( | Â [Report Spam]( An important message from our associates Greetings, Kyle D. here. Iâve been trading biotech stocks for 7 years. Over time, Iâve learned exactly where to find what I believe are the best trading opportunities hiding in this sector. But this time? [Itâs hiding in plain sight.]( I should know - Iâve been trading the pandemic market since March and Iâve [made over $3.5 million this year!]( [image]( [image]( Iâm not taking the pandemic lightly. I completely understand and respect the seriousness of it and its impact on all of us right now. But purely from a financial perspective - as a trader, there has never been an opportunity like this. It's what I believe is truly a once-in-a-lifetime chance. My eyes are fixated on the biotech industry as we work towards a COVID vaccine - which could be one of the biggest government contracts ever. Trump, China & Pfizer say the vaccine is coming before Election Day. This means winners and losers in the vaccine race could be determined in the next few weeks. Itâs what I am calling the [biggest biotech catalyst event of all time.]( In a recent update to my subscribers, I highlighted just how many COVID stocks Iâm focusing on in my watch list: [image]( But I donât just give traders names of stocks. When I'm trading on these COVID opportunities, you get my analysis and research, as well as my own entry and exit points. [I want you to join me]( and see exactly what Iâm doing, how Iâm doing it, and why Iâm doing it. Together, we could ride this wave to potential profits - [all you have to do is click HERE to start learning what you need to know.]( To more fully understand any Ragingbull.com, LLC (âRagingBullâ) subscription, website, application or other service (âServicesâ), please review our full disclaimer located at [( 8020Research (collectively, the âCompanyâ or âweâ used herein). The Company bears no responsibility or control over the content of the advertisement and/or the product or service offered.NO PURCHASE NECESSARY. This is a paid advertisement, Claims have not been independently verified. All of the content on our website and in our emails is for informational and illustrative purposes only, and should not be construed as an offer, or solicitation of an offer to buy or sell securities. You should always consult with a licensed securities professional before purchasing or selling securities.. Any results where shown are strictly hypothetical, and were executed in simulated trading accounts.CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.Earnings Disclaimer: Our website, blogs and emails use affiliate and advertising programs for monetization, which means when you click on ads or links, this can result in a commission that is credited to our company.Compliance: All header and reply-to information is accurate; you may reply directly to this email or send your reply to the physical address or email listed below. All opt-outs are automatically honored and managed by the system.Generally, the information regarding a company profiled or discussed on this website or email is provided from public sources. We make no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed.Questions regarding this may be sent to wealthweekly@8020research.info Your unique subscriber ID is: c35b5090289a030d5f71723db89dd233. Â [Unsubscribe]( | Â [Report Spam]( [Unsubscribe]( 8020 Publishing | Unit 16, 58 Marsh Wall, London E14 9TP, United Kingdom | +1 888 248 1957 | +44 (0) 20 3389 7119